Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

被引：0
作者：
Giuseppe Frasci
Giuseppe D'Aiuto
Pasquale Comella
Renato Thomas
Immacolata Capasso
Maurizio Di Bonito
Flavia Rivellini
Giacomo Carteni
Luigi De Lucia
Luigi Maiorino
Roberta D'Aniello
Pasquale Frezza
Liliana Lapenta
Giuseppe Comella
机构：
来源：
Breast Cancer Research and Treatment | 2000年 / 62卷
关键词：
breast cancer; paclitaxel; epirubicin; cisplatin; weekly administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose.It has been shown in vitro that both cisplatin and epirubicin increase the antitumor activity of paclitaxel. Weekly administration could give a substantial improvement in the therapeutic index of cisplatin and paclitaxel. This study was aimed at defining the antitumor activity of a weekly cisplatin–epirubicin–paclitaxel (PET) administration in locally advanced or metastatic breast cancer patients.
引用
收藏
页码：87 / 97
页数：10
相关论文
共 328 条
[1]  
Fossati R(1998)Polychemotherapy for early breast cancer: an overview of the randomized trials Lancet 352 930-942
[2]  
Confalonieri C(1998)Cytotoxic and hormonal treatment for metastatic breast cancer. A systematic review of published randomized trials involving 31,510 women J Clin Oncol 16 3439-3460
[3]  
Torri V(1996)Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer J Clin Oncol 14 2197-2205
[4]  
Ghislandi B(1991)Phase II trial of Taxol: An active drug in the treatment of metastatic breast cancer J Natl Cancer Inst 83 1797-1805
[5]  
Penna A(1995)Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response J Clin Oncol 13 1152-1159
[6]  
Pistotti V(1995)Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer J Clin Oncol 13 314-324
[7]  
Tinazzi A(1998)Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer J Clin Oncol 16 3353-3361
[8]  
Liberati A(1998)Weekly highdose paclitaxel demonstrates significant activity in advanced breast cancer (abstract) Proc Am Soc Clin Oncol 17 112a-2699
[9]  
Greenberg PA(1995)Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study J Clin Oncol 13 2688-2517
[10]  
Hortobagyi GN(1996)Phase II study of sequential combination of paclitaxel and doxorubicin in the treatment of advanced breast cancer (abstract) Proc Am Soc Clin Oncol 15 109-1814
12345678910